Company Filing History:
1 out of 1 
1 out of 3,578 
1 out of 817 
Years Active: 2003-2008
Title: Raquel Castellon: Innovator in Cancer and Neurotrophic Research
Introduction
Raquel Castellon is a prominent inventor based in Norwalk, CA (US). She has made significant contributions to the fields of cancer treatment and neurotrophic research. With a total of 4 patents, her work focuses on innovative methods that aim to improve health outcomes.
Latest Patents
One of her latest patents is titled "Methods for inhibiting cancer and scar formation." This invention discloses methods for inhibiting cancer, scar formation, disrupting the cellular cytoskeleton, and conferring resistance from infection. The methods involve the administration of oleuropein and/or the products of its hydrolysis in therapeutically effective amounts. A variety of pharmaceutical formulations and routes of administration are disclosed, which may be utilized to treat a wide variety of diseases. Another significant patent is related to the "Neurotrophic components of the ADNF I complex." This invention pertains to the Activity Dependent Neurotrophic Factor I complex (ADNF I complex) and polypeptides of this complex. These polypeptides produce neurotrophic effects through multiple proteases intrinsic to the ADNF I complex. The invention also includes pharmaceutical compositions comprising ADNF I complex polypeptides, as well as methods for reducing neuronal cell death in vitro and in vivo.
Career Highlights
Raquel has worked with notable organizations such as H2rc Corporation and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Some of her coworkers include Hamdi K Hamdi and Douglas E Brenneman. Their collaboration has likely enriched her research endeavors and contributed to her innovative patents.
Conclusion
Raquel Castellon is a dedicated inventor whose work in cancer and neurotrophic research has the potential to make a lasting impact on healthcare. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.